LABS score– a prognostic tool for FOLFOX4-treated advanced hepatocellular carcinoma and real-world efficacy: a single-center retrospective study

LABS score– a prognostic tool for FOLFOX4-treated advanced hepatocellular carcinoma and real-world efficacy: a single-center retrospective study

Abstract Background No widely used prognostic tool exists to demonstrate the benefit of oxaliplatin plus 5-fluorouracil/leucovorin (FOLFOX4) in patients with advanced hepatocellular carcinoma (HCC). We aimed to establish a prognostic score and demonstrate the real-world efficacy of FOLFOX4 chemother...

Full description

Bibliographic Details
Main Authors: Jirapat Wonglhow, Patrapim Sunpaweravong, Chirawadee Sathitruangsak, Arunee Dechaphunkul
Format: Article
Language:English
Published: BMC 2024-03-01
Series:BMC Cancer
Subjects:
Hepatocellular carcinoma
Liver cancer
Chemotherapy
FOLFOX
Prognostic score
Online Access:https://doi.org/10.1186/s12885-024-12040-z

Internet

https://doi.org/10.1186/s12885-024-12040-z

Similar Items